Money Times Talk

---

Get the latest Indian stock / share market highlights, BSE/NSE stock news, business research reports & details - updated daily by Money Times.

---

January 05, 2024

• ➢ NSE SME Plada Infotech has good return on equity, 3-years ROE is 25.6%. In October its IPO at Rs.48 was subscribed by 57.85 times & listed at 59. Now available around Rs.39. Buy for 30% gain.
• ➢ NSE SME Jayant Infratech recommended at RS.131 in MTT on 2nd Dec. hit a life time high of Rs.228 - a superb return of 74% in less than a month. It is now advisable to book partial profit.
• ➢ Heranba Industries exports 48% of sales, which set to grow further in USA & EU. Its NP shot up 2052% to Rs.32.51 cr. in Q2 from Rs.1.51 cr. in Q1FY24. It has huge reserves of Rs.776 cr. Promoters hold 75% & 18 HNIs hold 3.91%. Keep on radar for 30% gain.
• ➢ BSE SME Cosmic CRF was recommended at Rs.263 in MTTs of 4TH Nov. Stock hit new high of Rs.559 on 29th Dec.- a mind blowing returns of 113% in less than 2 months. Book partial profit.
• ➢ Indotech Transformers notched 431% higher Q2 PAT of Rs.7.07 cr. v/s Rs.1.33 cr. Y-o-Y. It won an order of Rs.62.70 cr. On 29th Dec., it hit new high of Rs.682. Keep on radar for good gains.
• ➢ Mumbai based Ruby Mills into textiles & real estate is available at attractive valuation with huge reserves of Rs.556 cr. on its equity of Rs.16.72 cr. Promoters hold 74.90%. & 15 HNIs hold 5.96%. Likely to cross its 52 weeks high Rs.269. Keep on your radar.
• ➢ Cash rich IOL Chemicals & Pharma is almost debt-free and posted 141% higher Q2 NP of Rs.37.79 cr. v/s Rs.15.67 cr. Q-o-Q and is likely to benefit further due to rising COVID cases. With huge reserve of Rs.1530 cr., it is the cheapest chemicals & pharma stock. Keep it on your radar for 30% gain.
• ➢ SJVN secures Rs.10,000 cr. construction finance to fund its renewable energy projects from a group of leading domestic & international lenders. Keep on your radar
• ➢ Artefact Projects bags new orders for 6 years in the last 6 months. It has pre-paid loan of Rs.5 cr. Share quotes way below its private placement price of Rs.111. HNIs hold 7.26% stake in it. Its Q2 NP rose 99% and it trades at a P/E of 9x and PB of 0.86x. Add for hefty gains.